The global ocular bromfenac market is a key segment of the ophthalmic therapeutics industry, primarily driven by its use as a non-steroidal anti-inflammatory drug (NSAID) to treat postoperative inflammation and pain following ocular surgeries, particularly cataract extraction. https://in.linkedin.com/company/data-bridge-market-research